Orexo eyes real-world testing of its modia opioid use disorder app

Orexo will start a new study of its modia app – used to treat people with opioid use disorder – to test how it performs in real-world settings.

The Swedish drugmaker has teamed up with consultancy ApexB.io and pharmacy group Magellan Rx Management on the study of the digital therapeutic, which provides tailored cognitive behavioural therapy (CBT) via a mobile device or PC.